Clinical trial
Study In Asthma Control
NCT00273026 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00273026 |
|---|---|
| Title | Study In Asthma Control |
| Official title | An Open-label, Multi-centre, Randomized, Parallel Group Clinical Effectiveness Study to Determine the Level of Asthma Control in Adolescent and Adult Patients With ADVAIR Versus Usual Care for 24 Weeks. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | salmeterol xinafoate/fluticasone propionate |
| Enrollment | 680 |
| Start date | Nov 8, 2004 |
| Completion | Mar 28, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Mar 21, 2018 |
| Countries | Canada |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: